-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on CVS Health, Raises Price Target to $101

Benzinga·12/10/2025 17:28:03
Listen to the news
Piper Sandler analyst Jessica Tassan reiterates CVS Health (NYSE:CVS) with a Overweight and raises the price target from $99 to $101.